01.22.2012 Leave a comment
I invite you to visit my new blog at the following address:
And my updated design portfolio at mathisworks.com
Explorations about graphic design and corporate communications
05.13.2011 Leave a comment
When a corporate reputation is under scrutiny, could slick communication save the day? Goldman Sachs is hoping with their annual report design.
The intended message
With all the accusations, Goldman’s messaging strategy is crucial. To sum it up: “We performed for our clients in 2010 and we’re hell-bent on continuing that. Also, we’re looking into where we might have gone wrong.”
To support this, the words harmonize with visuals: a steady dose of well-dressed people in well-dressed offices; global imagery exhibiting power; and some balanced touches of community outreach.
Their interactive version feels like it’s built for tablets, with spacious navigation and features designed to slide along a touch screen. If the medium is the message, then this is just one bit of proof that Goldman still cares about the details.
Is it working?
To put it crudely, Goldman’s visual message is one of stubbornness. They acknowledge a need for oversight and transparency with their words, but most of their content is geared to profit-driven clients and investors. They aim to be seen as unbreakable, unwavering, able to weather the storm without flinching. Concerns of the “general community” are addressed, but that isn’t their main point.
The question is, has it helped? The current media environment is none too flattering, so on the surface it doesn’t feel that way.
On the other hand, if you’re a client or investor, it could be comforting stuff.
04.09.2011 Leave a comment
Thursday night was nerve-wracking but worth it, as I was given a great opportunity to present to 20 or so eager grad students at Baruch College, my recent Alma Mater. The hour-long lecture covered graphic design in the communication context, and attempted to pin down as many concepts as possible in the time allotted. Lots of great Q&A at the end, so hopefully they got a lot out of it. I know I did.
The lecture was organized by the Baruch Corporate Communications Graduate Student Association, or the BCCGSA.
07.15.2010 2 Comments
Recently I saw a family of tourists on the subway, looking a little worn from walking through a strange (and humid) city. The father didn’t want to admit it, but he had no idea how long the train ride would be. He knew where he was going; at the moment the only thing he needed was the number of stops between here and there.
It was the perfect time to reflect on the new NYC Subway map. They’ve started installing it in trains and stations, and there is a rare opportunity to compare the old with the new in the map’s functional environment.
To the designers’ credit, distractions have been toned down. Lists have been trimmed, trainless Staten Island has shrunk, and distracting green parks have been muted (an improvement despite a browning effect). Manhattan is also wider to provide more breathing room.
The streamlining dilemma
Designers are quick to celebrate minimalist subway maps like Massimo Vignelli’s. MTA decision makers likely had a different approach, each one bringing a different argument to the table.
That tug-of-war seems evident here, and while the map has evolved in the right direction, the end product still attempts to satisfy many different uses simultaneously.
It leaves me to wonder if a stronger vision could have simplified the map even more, or even made multiple versions of the map for different environments.
In the end, of course, the designers and the department heads don’t matter. It’s all about that tourist, and getting him the info he needs at the right moment. For him, the MTA has at least taken steps in the right direction.
05.16.2010 Leave a comment
Pfizer’s new Annual Review document is out, and it’s time for shareholders to pay close attention. Some will focus on governance, others on amortization. I’m focused on the cover.
Two red-magenta spores, connected by a strand, explode visually over a dark background. We won’t know they’re cancer cells until we open and read. For now, they’re abstract objects representing science, art and fascination. Ditto for the typeface; the white dots on black evoke a movie marquis, or points of light in a dark, unknowing sky.
LogoLounge talks about the spore shape as a major design trend of 2010, its multiple arms “reaching out to convey a sense of connectivity and of serving multitudes.” That seems in line with Pfizer’s general message of science serving people. It could also be about product differentiation, to emphasize Pfizer’s point that “it is unwise to rely on one or two blockbuster drugs” (p17).
The connecting tendril may be the link between life and science. It could be a reassurance to people affected by the Pfizer-Wyeth merger. Or a battle cry of pharmaceutical researchers, like the ones pictured inside the book, who are challenged to connect the dots.
The general point is this: Pfizer based their cover design on this semi-abstract image, knowing that it would be seen by investors for at least the next year. It stands to reason that they would try and leverage the powers of emotion and ambiguity. Choices like these are rarely made by accident.
Of course, the rational fact that these are cancer cells should be compelling enough on its own. Here is a foe worthy of your investment dollars, no artsy interpretation needed.